SpringWorks Therapeutics Inc (NASDAQ: SWTX) is 12.88% higher on its value in year-to-date trading and has touched a low of $18.00 and a high of $53.92 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SWTX stock was last observed hovering at around $41.07 in the last trading session, with the day’s gains setting it 0.13%.
Currently trading at $41.20, the stock is 11.16% and 9.83% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.02 million and changing 0.32% at the moment leaves the stock 2.79% off its SMA200. SWTX registered 48.95% gain for a year compared to 6-month loss of -15.24%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 12.17% gain in the last 1 month and extending the period to 3 months gives it a 0.83%, and is 4.25% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.79% over the week and 6.56% over the month.
SpringWorks Therapeutics Inc (SWTX) has around 305 employees, a market worth around $3.06B and $86.19M in sales. Profit margin for the company is -349.32%. Distance from 52-week low is 128.89% and -23.59% from its 52-week high. The company has generated returns on investments over the last 12 months (-53.49%).
The EPS is expected to grow by 35.76% this year
298.0 institutions hold shares in SpringWorks Therapeutics Inc (SWTX), with institutional investors hold 111.76% of the company’s shares. The shares outstanding are 73.49M, and float is at 66.89M with Short Float at 19.88%. Institutions hold 109.40% of the Float.
The top institutional shareholder in the company is FMR LLC with over 11.11 million shares valued at $418.6 million. The investor’s holdings represent 15.0638 of the SWTX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 6.54 million shares valued at $246.53 million to account for 8.8715 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 5.62 million shares representing 7.6174 and valued at over $211.68 million, while DEEP TRACK CAPITAL, LP holds 5.0157 of the shares totaling 3.7 million with a market value of $139.38 million.
SpringWorks Therapeutics Inc (SWTX) Insider Activity
The most recent transaction is an insider sale by Islam Saqib, the company’s Chief Executive Officer. SEC filings show that Islam Saqib sold 49,000 shares of the company’s common stock on Jun 03 ’24 at a price of $39.90 per share for a total of $1.96 million. Following the sale, the insider now owns 1.11 million shares.
SpringWorks Therapeutics Inc disclosed in a document filed with the SEC on Jun 03 ’24 that Hambleton Julie (Director) sold a total of 4,648 shares of the company’s common stock. The trade occurred on Jun 03 ’24 and was made at $40.03 per share for $0.19 million. Following the transaction, the insider now directly holds 4095.0 shares of the SWTX stock.
Still, SEC filings show that on Jun 03 ’24, Edris Badreddin (Chief Operating Officer) disposed off 20,000 shares at an average price of $40.07 for $0.8 million. The insider now directly holds 249,600 shares of SpringWorks Therapeutics Inc (SWTX).
